Markets were rattled earlier this week after a fresh round of tariff threats reignited tensions between the U.S. and China. For a moment, it looked like the trade war narrative of 2018 was making a comeback. But by midweek, cooler heads prevailed, and stocks came roaring back.
The surprise? Small-cap stocks didn’t just recover,
Workiva built its name on simplifying complexity. Its platform acts as a connective layer between dozens of disconnected business tools, from Excel and SAP to cloud databases, bringing them together into one cohesive workspace.
Think of it as a control tower for enterprise reporting, where data flows seamlessly instead of being manually copied and pasted across spreadsheets and systems.
» Read more about: Why Should Investors Pay Attention To This AI Powerhouse »
Buffett’s firm has spent years amassing a giant stake in Occidental Petroleum (NYSE: OXY), starting with a $10 billion preferred stock and warrant package in 2019 that helped Occidental fund its acquisition of Anadarko.
By mid-2025, Berkshire had built that into a 32.7% equity position, making OXY one of its six largest holdings.
» Read more about: Berkshire’s $9.7 Billion OxyChem Deal Means What? »
Beneath the surface, Costco isn’t just about cheap gas, hot dogs, and fancy electronics, but the financial engine is far less obvious, and far more powerful than most casual shoppers realize.
If you’re thinking about buying Costco stock, understanding these three fundamentals could change how you see the company’s long-term investment case.
Annual fees generate the majority of net income,
For decades, Novo Nordisk was known mainly within the medical community as a quiet Danish powerhouse in diabetes care. Fast-forward to today, and its brand names are practically pop culture references. Wegovy and Ozempic have become synonymous with rapid weight loss, with late-night comedians, TikTok influencers, and even Hollywood scripts weaving them into conversation. Yet the company’s stock,
» Read more about: Why Novo May Be the Real Winner in Obesity Drug Boom »
Every once in a while, a company comes along that feels like the rare exception, a business so well-positioned, diversified, and forward-looking that it could anchor a portfolio for years.
Broadcom is one of those companies and it might be the single best position to hold for the foreseeable future.
Broadcom combines cyclical chip sales with high-margin recurring software revenue from acquisitions like CA,
Dentsply Sirona (NASDAQ: XRAY), one of the world’s largest makers of dental equipment and supplies, was created in 2016 when Dentsply merged with Sirona Dental Systems.
Fast forward to today, and the company is battling falling sales, mounting losses, and a stock price that has been hammered by more than 44% in the past year.
» Read more about: Is This Dental Stock a Stunning Bargain? »
In the short run, tariff headlines can turn Mr. Market into a nervous wreck. In the long run, owners do fine by owning scarce, low-cost assets run by rational people. Freeport-McMoRan fits that bill.
U.S. copper prices sold off after Washington excluded refined copper from its new 50% tariffs and instead targeted semi-finished products like wire,
» Read more about: Buffett Would Love This Moat, Freeport’s Hidden Growth Engine »
DigitalOcean (NASDAQ: DOCN) just pulled off something few small-cap tech companies have achieved in this market: record revenue, soaring profits, and a guidance hike that caught Wall Street flat-footed. The stock popped by almost a third after Q2 results, and yet, shares remain roughly 12% below where they started the year.
That gap between operational performance and valuation might be the opportunity hiding in plain sight.
» Read more about: The Best-Kept Secret in AI Infrastructure? Hint: It’s Not Nvidia »
After months of market jitters, earnings season has brought a wave of upbeat results, and stocks tied to improving outlooks are rallying hard.
Many investors who sat on the sidelines during the downturn are now realizing they may have missed some exceptional entry points.
But the best opportunities are about finding businesses with a runway long enough to turn today’s price into tomorrow’s fortune.
» Read more about: Could Lemonade’s AI Insurance Engine Turn $1 Billion Into $10 Billion »